top of page
cancer immunotherapy technology

Accellvecs Inc. provides natural killer T (NKT) cell-activating compound, alpha-galactosylceramide (KRN7000), which is not merely reagent manufactured in accordance with GMP, but is GMP-manufactured drug substance used in human clinical trials, thus ensuring high level of safety.


Accellvecs Inc. welcome all interested parties to contact us using our form.

Company Profile

Company Name  Accellvecs Inc.


Office  1-12-8, Shibuya, Shibuya-ku, Tokyo, 150-0002, Japan

Representative  President & CEO Yasuyuki Ishii


Contact Us

Please click Contact Form

bottom of page